Yeah, hard to imagine them actually admitting that they just got it wrong. But it does seem that way. Surely even purely from an insurance point of view it is cheaper to pay for a CxBladder test rather than the full invasive work up? Not to mention better for the patients (although I doubt this is much of a concern for them)
As you say, let's see. But it's certainly better to be supported by the urologists than not.
- Forums
- ASX - By Stock
- PEB
- Positive support from US Urological societies.
Positive support from US Urological societies., page-3
Featured News
Add PEB (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $66.57M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 122 | 8.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 122 | 0.083 |
1 | 37250 | 0.080 |
1 | 300000 | 0.069 |
1 | 100000 | 0.065 |
1 | 10000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 100000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.12pm 28/08/2024 (20 minute delay) ? |
Featured News
PEB (ASX) Chart |
Day chart unavailable
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online